Sheng, Xin http://orcid.org/0000-0002-3620-3577
Guan, Yuting http://orcid.org/0000-0003-1866-270X
Ma, Ziyuan http://orcid.org/0000-0002-1512-8993
Wu, Junnan http://orcid.org/0000-0002-0624-2057
Liu, Hongbo
Qiu, Chengxiang http://orcid.org/0000-0002-6346-8669
Vitale, Steven
Miao, Zhen http://orcid.org/0000-0002-3255-9517
Seasock, Matthew J. http://orcid.org/0000-0002-5940-5913
Palmer, Matthew
Shin, Myung K.
Duffin, Kevin L.
Pullen, Steven S.
Edwards, Todd L. http://orcid.org/0000-0003-4318-6119
Hellwege, Jacklyn N. http://orcid.org/0000-0001-7479-0920
Hung, Adriana M.
Li, Mingyao http://orcid.org/0000-0001-8180-0621
Voight, Benjamin F.
Coffman, Thomas M.
Brown, Christopher D.
Susztak, Katalin http://orcid.org/0000-0002-1005-3726
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01 DK105821, R01 DK087635, R01 DK076077)
Penn | Perelman School of Medicine, University of Pennsylvania (P30-DK050306, P30-DK19525)
Article History
Received: 24 November 2020
Accepted: 30 June 2021
First Online: 12 August 2021
Competing interests
: The Susztak laboratory receives funding from GlaxoSmithKline, Regeneron Pharmaceuticals, Gilead Sciences, Merck Sharp & Dohme, a subsidiary of Merck & Co., Boehringer Ingelheim, Bayer and Novo Nordisk. The funders had no influence on the data analysis. K.S. serves on the scientific advisory board of Jnana Therapeutics. The other authors declare no competing interests.